Company / Accounts Receivable
EXACT SCIENCES CORP Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$298.7M
FY2025
5-year range
$158.0M / $298.7M
FY2021-FY2025
Trend
+20.0%
vs FY2024
Sector context
#60 of 143
Health Care
What the data says
At $299M, EXACT SCIENCES CORP's accounts receivable ranks #60 of 143 in the Health Care sector. Accounts Receivable has increased for 3 consecutive years, from $158M in FY2022 to $299M in FY2025.
Based on SEC 10-K filings.
$299M in FY2025 with a 5-year CAGR of +5.1%.
Improved from $204M to $299M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +23.6%
- 5-Year CAGR
- +5.1%
- 10-Year CAGR
- -
Sector benchmark
#60 of 143 in Health CareTop 42% of 143This company $298.7M Sector average $1.3B
▼
-77.5% below sector average
Key checks
Key Insights
- EXACT SCIENCES CORP's accounts receivable has grown for 3 consecutive years.
- 5-year CAGR of +5.1%, indicating consistent growth.
- In FY2025, accounts receivable increased 20.0% year-over-year.
- Ranks #60 out of 143 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $298.7M | +20.0% |
| FY2024 | $249.0M | +22.3% |
| FY2023 | $203.6M | +28.8% |
| FY2022 | $158.0M | -27.0% |
| FY2021 | $216.6M | -7.1% |
| FY2020 | $233.2M | +78.9% |
| FY2019 | $130.4M | +187.6% |
| FY2018 | $45.3M | +71.6% |
| FY2017 | $26.4M | +209.9% |
| FY2016 | $8.5M | +72.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026